Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Mark A Goldsmith. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Mark A Goldsmith har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:RVMD / Revolution Medicines, Inc. | See Remarks, Director | 465 720 |
Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Mark A Goldsmith. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp RVMD / Revolution Medicines, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i RVMD / Revolution Medicines, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i RVMD / Revolution Medicines, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Mark A Goldsmith som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 37 000 | 465 720 | 8,63 | 0,54 | 19 980 | 251 489 | |
2025-06-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −13 496 | 428 720 | −3,05 | 39,83 | −537 546 | 17 075 918 |
2025-03-19 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 738 | 441 564 | −2,59 | 39,04 | −458 255 | 17 238 791 |
2025-03-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 97 400 | 453 302 | 27,37 | ||||
2024-12-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 30 846 | 355 902 | 9,49 | 0,49 | 15 115 | 174 392 | |
2024-12-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 714 | 325 056 | −3,48 | 45,40 | −531 860 | 14 758 778 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 36 600 | 336 770 | 12,19 | 0,49 | 17 934 | 165 017 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −50 900 | 300 170 | −14,50 | 55,56 | −2 827 821 | 16 676 365 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 50 900 | 351 070 | 16,96 | 4,09 | 208 181 | 1 435 876 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 20 424 | −19,67 | 55,02 | −275 104 | 1 123 747 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 20 424 | −19,67 | 55,03 | −275 134 | 1 123 867 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −9 100 | 300 170 | −2,94 | 55,02 | −500 714 | 16 516 404 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 9 100 | 309 270 | 3,03 | 4,09 | 37 219 | 1 264 914 |
2024-10-15 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −30 000 | 300 170 | −9,09 | 50,36 | −1 510 773 | 15 116 291 |
2024-10-15 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 30 000 | 330 170 | 9,99 | 4,09 | 122 700 | 1 350 395 |
2024-10-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −2 022 | 300 170 | −0,67 | 45,46 | −91 913 | 13 644 708 |
2024-10-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 978 | 302 192 | −2,57 | 44,80 | −357 409 | 13 537 990 |
2024-10-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 000 | 310 170 | 3,33 | 4,09 | 40 900 | 1 268 595 |
2024-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 715 | 300 170 | −3,76 | 44,19 | −517 631 | 13 263 102 |
2024-08-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −3 217 | 311 885 | −1,02 | 46,48 | −149 519 | 14 495 760 |
2024-08-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −6 783 | 315 102 | −2,11 | 45,60 | −309 308 | 14 368 777 |
2024-08-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 000 | 321 885 | 3,21 | 4,09 | 40 900 | 1 316 510 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 25 424 | −16,43 | 45,01 | −225 059 | 1 144 380 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 25 424 | −16,43 | 45,01 | −225 058 | 1 144 375 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −25 000 | 311 885 | −7,42 | 45,05 | −1 126 205 | 14 049 858 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 25 000 | 336 885 | 8,02 | 4,09 | 102 250 | 1 377 860 |
2024-06-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 950 | 311 885 | −3,69 | 37,39 | −446 770 | 11 660 320 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −901 | 322 322 | −0,28 | 40,93 | −36 881 | 13 193 703 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 699 | 323 223 | −1,73 | 39,99 | −227 880 | 12 924 363 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −900 | 328 922 | −0,27 | 39,09 | −35 182 | 12 857 857 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 7 500 | 329 822 | 2,33 | 4,09 | 30 675 | 1 348 972 |
2024-04-12 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 30 424 | −14,11 | 35,34 | −176 687 | 1 075 105 |
2024-04-12 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 30 424 | −14,11 | 35,33 | −176 658 | 1 074 932 |
2024-04-12 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 500 | 452 879 | −1,63 | 35,48 | −266 122 | 16 069 460 |
2024-03-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 788 | 460 379 | −1,24 | 31,58 | −182 804 | 14 540 242 |
2024-03-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | −90 000 | 466 167 | −16,18 | ||||
2023-12-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −8 165 | 376 167 | −2,12 | 25,90 | −211 488 | 9 743 402 |
2023-10-24 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 35 000 | 384 332 | 10,02 | 0,49 | 17 150 | 188 323 | |
2023-09-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −8 054 | 349 332 | −2,25 | 31,31 | −252 175 | 10 937 760 | |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 35 424 | −12,37 | 35,04 | −175 219 | 1 241 392 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 35 424 | −12,37 | 35,04 | −175 191 | 1 241 193 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −30 000 | 357 386 | −7,74 | 35,05 | −1 051 563 | 12 527 130 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 12 007 | 387 386 | 3,20 | 1,12 | 13 448 | 433 872 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 17 993 | 375 379 | 5,03 | 0,54 | 9 716 | 202 705 |
2023-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 104 000 | 355 872 | 41,29 | ||||
2023-02-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 45 000 | 251 872 | 21,75 | 0,49 | 22 050 | 123 417 | |
2022-08-15 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 10 000 | 206 872 | 5,08 | 0,49 | 4 900 | 101 367 | |
2022-08-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 10 336 | 196 872 | 5,54 | 0,49 | 5 065 | 96 467 | |
2022-03-21 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 023 | 185 599 | −0,55 | 18,61 | −19 042 | 3 454 758 | |
2022-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
A - Award | 363 000 | 363 000 | |||||
2022-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 104 000 | 186 622 | 125,87 | ||||
2021-12-21 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 571 | 82 622 | −1,87 | 24,41 | −38 348 | 2 016 803 | |
2021-12-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | −37 721 | 167 782 | −18,36 | ||||
2021-12-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 37 721 | 84 193 | 81,17 | 0,49 | 18 483 | 41 255 | |
2021-09-21 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 531 | 46 472 | −3,19 | 30,02 | −45 961 | 1 395 089 | |
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Options (Right to buy) |
D - Sale to Issuer | −13 171 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −9 083 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −12 446 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −13 171 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −6 825 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −13 171 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −89 857 | 0 | −100,00 | ||||
2021-06-22 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −20 | 48 003 | −0,04 | 33,50 | −670 | 1 607 947 | |
2021-06-22 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 465 | 48 023 | −2,96 | 34,13 | −50 000 | 1 639 025 | |
2021-06-04 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 13 171 | 13 171 | |||||
2021-03-08 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −14 987 | 0 | −100,00 | ||||
2021-03-08 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 987 | 14 987 | |||||
2021-03-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
A - Award | 169 000 | 169 000 | |||||
2021-03-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 48 000 | 48 744 | 6 451,61 | ||||
2021-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 58 486 | −7,88 | |||
2021-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 744 | −87,05 | 46,00 | −229 981 | 34 221 |
2021-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 744 | 672,04 | 1,12 | 5 600 | 6 433 |
2021-02-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 63 486 | −19,11 | |||
2021-02-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −15 000 | 744 | −95,27 | 55,00 | −825 000 | 40 920 |
2021-02-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 15 000 | 15 744 | 2 016,13 | 1,12 | 16 800 | 17 633 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 78 486 | −5,99 | |||
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −800 | 744 | −51,81 | 46,26 | −37 005 | 34 415 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 200 | 1 544 | −73,12 | 45,26 | −190 096 | 69 883 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 744 | 672,04 | 1,12 | 5 600 | 6 433 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
G - Gift | −246 604 | 247 093 | −49,95 | ||||
2020-12-28 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 020 | 139 043 | −2,81 | 35,02 | −140 769 | 4 868 897 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −30 | 83 486 | −0,04 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −42 548 | 520 841 | −7,55 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 312 | 71 879 | −1,79 | 34,12 | −44 762 | 2 452 339 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −42 578 | 0 | −100,00 | 34,40 | −1 464 854 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 30 | 42 578 | 0,07 | 1,12 | 34 | 47 687 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 42 548 | 42 548 | 4,73 | 201 252 | 201 252 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −20 076 | 563 389 | −3,44 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 447 | 331 229 | −3,06 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −21 088 | 73 191 | −22,37 | 34,08 | −718 652 | 2 494 254 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −30 523 | 0 | −100,00 | 34,14 | −1 041 918 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 20 076 | 30 523 | 192,17 | 4,73 | 94 959 | 144 374 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 447 | 10 447 | 4,09 | 42 728 | 42 728 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 132 | 341 676 | −2,88 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 500 | 94 279 | −7,37 | 34,08 | −255 605 | 3 213 094 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −10 132 | 0 | −100,00 | 34,11 | −345 567 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 132 | 10 132 | 4,09 | 41 440 | 41 440 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −100 | 351 808 | −0,03 | |||
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 101 779 | −0,10 | 34,02 | −3 402 | 3 462 522 |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 34,01 | −3 401 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 100 | 100 | 4,09 | 409 | 409 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 097 | 351 908 | −2,79 | |||
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −541 | 101 879 | −0,53 | 33,00 | −17 853 | 3 362 007 |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −10 097 | 0 | −100,00 | 33,15 | −334 713 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 097 | 10 097 | 4,09 | 41 297 | 41 297 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −29 903 | 362 005 | −7,63 | |||
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 459 | 102 420 | −10,06 | 33,00 | −378 173 | 3 380 096 |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −29 903 | 0 | −100,00 | 33,00 | −986 850 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 29 903 | 29 903 | 4,09 | 122 303 | 122 303 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −6 056 | 391 908 | −1,52 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 286 | 83 516 | −1,52 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −712 | 113 879 | −0,62 | 31,05 | −22 106 | 3 535 613 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 32,18 | −6 437 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 142 | 200 | −97,28 | 31,66 | −226 084 | 6 331 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 6 056 | 7 342 | 470,92 | 4,09 | 24 769 | 30 029 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 286 | 1 286 | 1,12 | 1 440 | 1 440 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −27 363 | 84 802 | −24,40 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 288 | 114 591 | −8,97 | 31,03 | −350 311 | 3 556 206 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −22 658 | 0 | −100,00 | 31,04 | −703 191 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 705 | 22 658 | −17,19 | 29,76 | −140 030 | 674 347 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 27 363 | 27 363 | 1,12 | 30 647 | 30 647 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −8 813 | 112 165 | −7,28 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −8 813 | 0 | −100,00 | 29,04 | −255 956 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 8 813 | 8 813 | 1,12 | 9 871 | 9 871 | |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 544 | 120 978 | −2,06 | |||
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 399 | 125 879 | −3,38 | 29,00 | −127 571 | 3 650 491 |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −2 544 | 0 | −100,00 | 29,07 | −73 948 | |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 2 544 | 2 544 | 1,12 | 2 849 | 2 849 | |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 130 251 | −0,08 | 29,00 | −2 900 | 3 777 279 |
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −900 | 123 522 | −0,72 | |||
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −900 | 130 351 | −0,69 | 29,05 | −26 141 | 3 786 097 |
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −900 | 0 | −100,00 | 29,05 | −26 145 | |
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 900 | 900 | 1,12 | 1 008 | 1 008 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −500 | 124 422 | −0,40 | |||
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −700 | 131 251 | −0,53 | 29,07 | −20 352 | 3 816 031 |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 29,07 | −14 533 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 500 | 500 | 1,12 | 560 | 560 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 100 | 124 922 | −0,87 | |||
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −800 | 131 951 | −0,60 | 29,02 | −23 213 | 3 828 717 |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 100 | 0 | −100,00 | 29,05 | −31 960 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 100 | 1 100 | 1,12 | 1 232 | 1 232 | |
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 438 | 126 022 | −1,13 | |||
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 101 | 132 751 | −0,82 | 29,01 | −31 939 | 3 850 987 |
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 438 | 0 | −100,00 | 29,01 | −41 713 | |
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 438 | 1 438 | 1,12 | 1 611 | 1 611 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −9 700 | 127 460 | −7,07 | |||
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −3 900 | 133 852 | −2,83 | 27,57 | −107 522 | 3 690 259 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 232 | 0 | −100,00 | 28,28 | −147 978 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 5 232 | 5 232 | 1,12 | 5 860 | 5 860 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 468 | 0 | −100,00 | 27,49 | −122 809 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 4 468 | 4 468 | 1,12 | 5 004 | 5 004 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −16 967 | 137 160 | −11,01 | |||
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 137 752 | −0,07 | 27,51 | −2 751 | 3 789 558 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −600 | 137 852 | −0,43 | 26,76 | −16 054 | 3 688 465 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 400 | 138 452 | −3,75 | 25,79 | −139 249 | 3 570 234 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −400 | 0 | −100,00 | 27,72 | −11 090 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 400 | 400 | 1,12 | 448 | 448 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 983 | 0 | −100,00 | 26,63 | −52 811 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 983 | 1 983 | 1,12 | 2 221 | 2 221 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −14 584 | 0 | −100,00 | 25,77 | −375 859 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 14 584 | 14 584 | 1,12 | 16 334 | 16 334 | |
2020-06-08 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Options (Right to buy) |
A - Award | 13 171 | 13 171 | |||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −1 300 | 12 446 | −9,46 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −300 | 6 825 | −4,21 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −2 625 | 14 987 | −14,90 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 225 | 143 063 | −2,87 | 50,05 | −211 474 | 7 160 747 |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 300 | 147 288 | 0,89 | 7,60 | 9 880 | 1 119 389 | |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 300 | 145 988 | 0,21 | 11,50 | 3 450 | 1 678 862 | |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 625 | 145 688 | 1,83 | 1,55 | 4 069 | 225 816 | |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −100 | 17 612 | −0,56 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 143 063 | −0,07 | 50,00 | −5 000 | 7 153 150 |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 100 | 143 163 | 0,07 | 1,55 | 155 | 221 903 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −3 900 | 13 746 | −22,10 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −750 | 7 125 | −9,52 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −6 813 | 17 712 | −27,78 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 463 | 143 063 | −7,42 | 45,06 | −516 545 | 6 446 691 |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 900 | 154 526 | 2,59 | 7,60 | 29 640 | 1 174 398 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 150 626 | 0,50 | 11,50 | 8 625 | 1 732 199 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 813 | 149 876 | 4,76 | 1,55 | 10 560 | 232 308 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −520 | 17 646 | −2,86 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −300 | 7 875 | −3,67 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −2 325 | 24 525 | −8,66 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 145 | 143 063 | −2,15 | 40,01 | −125 824 | 5 723 607 |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 520 | 146 208 | 0,36 | 7,60 | 3 952 | 1 111 181 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 300 | 145 688 | 0,21 | 11,50 | 3 450 | 1 675 412 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 325 | 145 388 | 1,63 | 1,55 | 3 604 | 225 351 | |
2020-04-29 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −400 | 26 850 | −1,47 | ||||
2020-04-29 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 143 063 | −0,28 | 40,12 | −16 049 | 5 740 045 |
2020-04-29 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 400 | 143 463 | 0,28 | 1,55 | 620 | 222 368 | |
2020-02-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
A - Award | 128 439 | 128 439 | |||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
1 130 268 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
780 912 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
1 130 268 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
780 912 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
1 130 268 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
780 912 | ||||||||
2019-06-10 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 13 171 | 13 171 | |||||
2018-07-20 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 175 | 8 175 | |||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
273 410 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
155 779 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
273 410 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
155 779 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
273 410 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
155 779 |